Ozempic and Mounjaro causing Muscle Loss ???
Published on July 12, 2025
Summary authored by editor@wellifi.com
TLDR Summary
GLP-1 agonists such as Ozempic and Manjaro may cause some muscle loss, but they lead to significantly greater fat loss. Implementing resistance training, adequate protein intake, and maintaining quality sleep are essential strategies to preserve muscle mass during weight loss.
Key Points
- GLP-1 agonists like Ozempic and Manjaro can lead to some muscle loss, but fat loss is significantly greater.
- Studies show that the proportion of fat loss compared to lean mass loss is favorable for those using GLP-1 medications.
- Resistance training, adequate protein intake, and quality sleep are key strategies to preserve lean muscle while losing weight.
Understanding GLP-1 Agonists: Debunking Myths About Muscle Loss
In recent discussions surrounding GLP-1 agonists like Ozempic, Wegovy, and Manjaro, there have been numerous rumors suggesting that these medications may lead to muscle loss. Some social media platforms have fueled these claims, suggesting that people are becoming fatter while using these drugs. In this article, we aim to dissect these myths with evidence and provide valuable insights into how to maintain muscle mass while utilizing these treatments.
What Are GLP-1 Agonists?
GLP-1 agonists are medications that help regulate appetite and blood sugar levels. Ozempic and Wegovy are two popular GLP-1 agonists derived from the same active ingredient, semaglutide. Manjaro, also known as terzepatide, is a newer option that combines GLP-1 activity with additional mechanisms to enhance fat burning. Despite concerns about muscle loss, scientific evidence suggests that the benefits of fat loss outweigh the potential downsides regarding lean body mass.
Examining the Evidence
Research, including studies from 2017 and 2020, indicates that while these medications do lead to a small decrease in lean body mass, they result in a significantly greater loss of fat mass. For instance:
- A 2017 study demonstrated a three-fold greater loss of fat compared to lean body mass after 12 weeks of semaglutide treatment.
- A 2020 study showed an increase in lean mass by 1.2% among participants.
- The renowned 2021 study published in the New England Journal of Medicine reported an overall five-kilogram loss of lean body mass, but with an eight-kilogram loss of fat mass, resulting in a proportional increase in lean mass of three percent.
Interestingly, the placebo group in these studies experienced a greater loss of lean mass than those receiving Ozempic, which indicates that the drug may help preserve muscle mass better than not taking it at all.
Understanding Manjaro
Manjaro, or terzepatide, is unique as it acts as both a GLP-1 agonist and a GIP agonist. This dual action enhances its efficacy in fat reduction while preserving lean mass. Research from the SURMOUNT-1 trial showed that participants on Manjaro experienced a fat mass reduction that was three times greater than the reduction in lean mass.
Strategies to Preserve Lean Body Mass
While weight loss is beneficial, it’s essential to implement strategies to maintain or even increase lean body mass when using GLP-1 medications. Here are three effective approaches:
1. Engage in Resistance Training
Incorporating resistance training, such as weight lifting or high-intensity interval training (HIIT), can significantly help preserve muscle mass. Aim for at least 150 minutes of moderate to high-intensity exercise each week.
2. Ensure Adequate Protein Intake
Consuming enough protein is vital to minimize lean mass loss during weight loss. An approximate intake of 75 grams of protein per day is recommended, though individual needs may vary. Studies have shown that higher protein intake correlates with less lean mass loss and more fat mass loss.
3. Prioritize Quality Sleep
Quality sleep is crucial for muscle maintenance and overall health. Sleep deprivation can lead to hormonal imbalances that increase hunger and cravings, making it harder to maintain a healthy weight. Optimizing sleep patterns can promote the secretion of growth hormone, which plays a role in muscle growth and regeneration.
Conclusion
While concerns about muscle loss with GLP-1 agonists like Ozempic, Wegovy, and Manjaro are valid, the evidence suggests that these medications lead to more fat loss than muscle loss. By integrating resistance training, maintaining adequate protein intake, and prioritizing restorative sleep, individuals can effectively manage their body composition while utilizing these treatments. It is crucial to work under the supervision of a qualified healthcare professional to tailor a personalized approach to weight loss and health management.
If you're considering these medications or have questions about your weight loss journey, consult with a healthcare provider who understands your needs and can guide you effectively.